Sign in

NCT07731958Recruiting

Unilateral vs. Bilateral Lung Volume Reduction Surgery

Unilateral Versus Bilateral Lung Volume Reduction Surgery for Patients With Severe COPD

Source: ClinicalTrials.gov · Last updated 28 Jul 2026

Brief summary (registry, in English)

This study compares two surgical approaches for patients with severe Chronic Obstructive Pulmonary Disease (COPD) and severe emphysema: unilateral (operating on one lung) versus bilateral (operating on both lungs) lung volume reduction surgery (LVRS).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
146 (estimated)
First submitted
17 Jul 2026
Start date
21 Mar 2025
Primary completion date
Jul 2031
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Diseases
COPD
NCT number
NCT07731958

What you commit to

  • Study type: Interventional
  • Planned participants: 146
  • From 21 Mar 2025 to the primary completion date, Jul 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Massive adhesions during surgery assessed by the surgeon indicating problems postoperatively
  • Perioperative decision on not doing operation on the other side (medical, surgical or anaesthesiologic problems that favours a fast termination of the surgery, decided by the team in OR).
  • Previous cardiothoracic surgery

Other illness

  • Psychiatric disorder (anxiety, depression, schizophrenia)
  • Simultaneous lung cancer surgery
  • Increased risk of post-operative bleeding assessed perioperatively by the surgeon.

Lab values

  • Increased bleeding risk (e.g., preoperative INR \>2, overdue discontinuation of anticoagulants according to guidelines by the Danish Society for Thrombosis and Haemostasis, known coagulopathy).

Other

  • Dependent on wheelchair
  • Living in nursery home
  • Dependent on walker device

Who the study is looking for

  • Suitable target areas in both lungs
  • Age ≥ 18 years.
  • Speaks and understands Danish or English
  • Informed consent obtained
  • Usual inclusion criteria in LVRS:
    • Moderate to severe COPD with MRC score \> 2 \< 75 years old 17 \< BMI \> 30 FEV1 \> 20% and \< 45% of predicted RV \> 200% of predicted as a sign of relevant hyperinflation DLCO \> 20% of predicted The patient should be in ideal medical treatment and have completed rehabilitation A high-resolution CT \< 3 months old should follow the referral to MDT Absence of nodules suspicious of malignancy on CT scan Absence of significant comorbidity including severe cardiovascular disease LVEF normal Absence of pulmonary hypertension, TI-gradient \< 40 mmHg Absence of chronic or frequent lung infections Smoking abstinence six months prior to surgery Assessed as sufficiently physically fit to undergo surgery and rehabilitation

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Rigshospitalet
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.